These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 10084454)

  • 81. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.
    Mandell LA; Wunderink RG; Anzueto A; Bartlett JG; Campbell GD; Dean NC; Dowell SF; File TM; Musher DM; Niederman MS; Torres A; Whitney CG; ;
    Clin Infect Dis; 2007 Mar; 44 Suppl 2(Suppl 2):S27-72. PubMed ID: 17278083
    [No Abstract]   [Full Text] [Related]  

  • 82. Revised SWAB guidelines for antimicrobial therapy of community-acquired pneumonia.
    Schouten JA; Prins JM; Bonten MJ; Degener J; Janknegt RE; Hollander JM; Jonkers RE; Wijnands WJ; Verheij TJ; Sachs AP; Kullberg BJ;
    Neth J Med; 2005 Sep; 63(8):323-35. PubMed ID: 16186645
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A national confidential enquiry into community acquired pneumonia deaths in young adults in England and Wales. British Thoracic Society Research Committee and Public Health Laboratory Service.
    Simpson JC; Macfarlane JT; Watson J; Woodhead MA
    Thorax; 2000 Dec; 55(12):1040-5. PubMed ID: 11083890
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Lower respiratory tract infection and pneumonia in the community.
    Macfarlane J
    Semin Respir Infect; 1999 Jun; 14(2):151-62. PubMed ID: 10391409
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Severity assessment scores to guide empirical use of antibiotics in community acquired pneumonia.
    Singanayagam A; Chalmers JD
    Lancet Respir Med; 2013 Oct; 1(8):653-662. PubMed ID: 24461668
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Adult community-acquired pneumonia caused by macrolide resistant Mycoplasma pneumoniae.
    Isozumi R; Yoshimine H; Morozumi M; Ubukata K; Ariyoshi K
    Respirology; 2009 Nov; 14(8):1206-8. PubMed ID: 19732389
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Prognostic factors in hospitalized community-acquired pneumonia: a retrospective study of a prospective observational cohort.
    Ito A; Ishida T; Tokumasu H; Washio Y; Yamazaki A; Ito Y; Tachibana H
    BMC Pulm Med; 2017 May; 17(1):78. PubMed ID: 28464807
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The newer guidelines for the management of community-acquired pneumonia.
    Shah PB; Giudice JC; Griesback R; Morley TF; Vasoya A
    J Am Osteopath Assoc; 2004 Dec; 104(12):521-6. PubMed ID: 15653779
    [TBL] [Abstract][Full Text] [Related]  

  • 89. International guidelines for the treatment of community-acquired pneumonia in adults: the role of macrolides.
    File TM; Tan JS
    Drugs; 2003; 63(2):181-205. PubMed ID: 12515565
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Community-acquired pneumonia in the elderly.
    Fung HB; Monteagudo-Chu MO
    Am J Geriatr Pharmacother; 2010 Feb; 8(1):47-62. PubMed ID: 20226392
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Evaluation of community acquired pneumonia guidelines.
    Ravago TS; Mosniam J; Alem F
    J Med Syst; 2000 Oct; 24(5):289-96. PubMed ID: 11103359
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Guidelines for the management of adults with health care-associated pneumonia: implications for nursing facility residents.
    Guay DR
    Consult Pharm; 2006 Sep; 21(9):719-25. PubMed ID: 17069468
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Nonvalue of the initial microbiological studies in the management of nonsevere community-acquired pneumonia.
    Theerthakarai R; El-Halees W; Ismail M; Solis RA; Khan MA
    Chest; 2001 Jan; 119(1):181-4. PubMed ID: 11157602
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Influence of deviation from guidelines on the outcome of community-acquired pneumonia.
    Menéndez R; Ferrando D; Vallés JM; Vallterra J
    Chest; 2002 Aug; 122(2):612-7. PubMed ID: 12171840
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Clinical perspectives on the management of community-acquired pneumonia.
    Garau J
    Diagn Microbiol Infect Dis; 1996 Aug; 25(4):205-11. PubMed ID: 8937846
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Guidelines for the management of community-acquired pneumonia. Current recommendations and antibiotic selection issues.
    Niederman MS
    Med Clin North Am; 2001 Nov; 85(6):1493-509. PubMed ID: 11680113
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Assessing the efficacy of antimicrobial agents based on the Japanese Respiratory Society Guidelines for a community-acquired pneumonia].
    Sasaki E; Kaida H; Izumikawa K; Hayakawa T; Izumikawa K; Hara K
    Kansenshogaku Zasshi; 2002 Jul; 76(7):550-7. PubMed ID: 12212321
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Primary care summary of the British Thoracic Society Guidelines for the management of community acquired pneumonia in adults: 2009 update. Endorsed by the Royal College of General Practitioners and the Primary Care Respiratory Society UK.
    Levy ML; Le Jeune I; Woodhead MA; Macfarlaned JT; Lim WS;
    Prim Care Respir J; 2010 Mar; 19(1):21-7. PubMed ID: 20157684
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Community-acquired pneumonia. Diagnostic and therapeutic approach.
    Cunha BA
    Med Clin North Am; 2001 Jan; 85(1):43-77. PubMed ID: 11190352
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Rationale for producing evidence-based guidelines for community-acquired pneumonia in the Gulf Corporation Council.
    Memish ZA; Ahmed QA; Arabi Y; Shibl AM; Niederman MS;
    J Chemother; 2007 Oct; 19 Suppl 1():13-6. PubMed ID: 18073165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.